Ads
related to: pharmaceutical industrydirexion.com has been visited by 100K+ users in the past month
- Healthcare ETF
Direxion Daily Healthcare ETF
Bull 3X Shares ETF - CURE
- Bull & Bear 3X ETFs
Fixed Income, International Equity
Market Cap And Sector Equity
- ETF Education
View Our Educational Library to
Learn More About Our Products.
- ETF Line-up
View Direxion's Complete List of
Leveraged and Inverse ETFs.
- Healthcare ETF
Search results
CMO/CDMO Market Expected to Reach USD 41.75 Billion by 2030: A Deep Dive into Growth Drivers
Digital Journal· 12 hours agoThe Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 3 days agoHEALTH NEWS The Federal Trade Commission is challenging hundreds of pharmaceutical patent listings...
Here's Why You Should Retain STERIS (STE) Stock for Now
Zacks via Yahoo Finance· 2 days agoSTERIS plc STE is likely to grow in the coming quarters, backed by the promising recovery potential...
The Bird Flu Outbreak Has More Questions Than Answers
Bloomberg· 3 days agoThe spread of H5N1 at dairy farms keeps surprising scientists. Lisa Jarvis is a Bloomberg Opinion...
Recombinant Proteins Market to Reach USD 5.8 Billion by 2030, Prominent Players Shaping the Industry...
Digital Journal· 11 hours agoThe Recombinant Proteins Market has witnessed remarkable growth in recent years, driven by...
Digital Health Sector Slowed Down in 2023
Medscape· 24 hours agoAlthough the average amount raised in European funding rounds decreased, the number of investors increased by nearly one quarter.
Lyra Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 2 days agoEarnings per share (EPS) missed analyst estimates by 28%. Looking ahead, revenue is forecast to grow...
Daniel Skovronsky
Time Magazine· 2 days agoIt’s been a banner year for pharmaceutical giant Eli Lilly, mainly thanks to the persistence of Dr. Daniel Skovronsky, its chief scientific officer....
Europe’s AI Paradox: Slow Adoption, Big Ambitions
PYMNTS.com· 2 days agoDespite Europe’s reputation as a tech laggard, a cadre of companies is making big bets on artificial intelligence (AI). While the region has been slow to...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Associated Press via Yahoo News· 3 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
